SynthesisFrontiers in endocrinology2022

Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis.

Jinjing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.